Differential distribution of U6 (RNU6-1) expression in human carcinoma tissues demonstrates the requirement for caution in the internal control gene selection for microRNA quantification

Lou,Ge; Ma,Ning; Xu,Ya; Jiang,Lei; Yang,Jing; Wang,Chuxuan; Jiao,Yufei; Gao,Xu

doi:10.3892/ijmm.2015.2338

Differential distribution of U6 (RNU6-1) expression in human carcinoma tissues demonstrates the requirement for caution in the internal control gene selection for microRNA quantification

Authors:
- Ge Lou
- Ning Ma
- Ya Xu
- Lei Jiang
- Jing Yang
- Chuxuan Wang
- Yufei Jiao
- Xu Gao
View Affiliations

Affiliations: Department of Pathology, The Second Affiliated Hospital of Harbin Medical University, Harbin 150086, P.R. China, Department of Biochemistry and Molecular Biology, Harbin Medical University, Harbin 150081, P.R. China
Published online on: September 7, 2015 https://doi.org/10.3892/ijmm.2015.2338
Pages: 1400-1408

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Alterations in microRNA (miRNA) expression patterns have been associated with a number of human diseases. Accurate quantitation of miRNA levels is important for their use as biomarkers and in determining their functions. Although the issue of proper miRNA detection was solved with the introduction of standard reverse transcription‑quantitative polymerase chain reaction (RT‑qPCR) assays, numerous issues with the selection of appropriate internal control genes remain. U6 (RNU6‑1) snRNA, the most commonly used internal control gene in miRNA RT‑qPCR assays, was shown to be unstable in clinical samples, particularly cancer tissues. Identification of the distribution of U6 in different tissues is the premise of more accurate quantification of miRNAs. However, the distribution of U6 in human carcinoma tissues and corresponding normal tissues is unknown. In the present study, U6 levels were significantly higher in human breast carcinoma tissues compared with the corresponding normal tissues by RT‑qPCR. In the carcinoma or corresponding adjacent normal tissues, the expression levels of U6 in epithelial cells were higher than those in the mesenchymal cells. Furthermore, the expression levels of U6 in the carcinoma tissues of the liver and intrahepatic bile ducts were higher than those in the adjacent normal tissues. These results suggest that the expression and distribution of U6 exhibits a high degree of variability among several types of human cells. Therefore, caution is required when selecting U6 as an internal control gene for evaluating expression profiles of miRNAs in patients with carcinoma, particularly carcinoma of the liver and intrahepatic bile ducts.

View Figures

View References

1	Jovanovic M and Hengartner MO: miRNAs and apoptosis: RNAs to die for. Oncogene. 25:6176–6187. 2006. View Article : Google Scholar : PubMed/NCBI
2	Listowski MA, Heger E, Bogusławska DM, Machnicka B, Kuliczkowski K, Leluk J and Sikorski AF: microRNAs: Fine tuning of erythropoiesis. Cell Mol Biol Lett. 18:34–46. 2013. View Article : Google Scholar
3	Farazi TA, Hoell JI, Morozov P and Tuschl T: MicroRNAs in human cancer. Adv Exp Med Biol. 774:1–20. 2013. View Article : Google Scholar : PubMed/NCBI
4	Luzna P, Gregar J, Uberall I, Radova L, Prochazka V and Ehrmann J Jr: Changes of microRNAs-192, 196a and 203 correlate with Barrett's esophagus diagnosis and its progression compared to normal healthy individuals. Diagn Pathol. 6(114)2011. View Article : Google Scholar : PubMed/NCBI
5	Mao ZG, He DS, Zhou J, Yao B, Xiao WW, Chen CH, Zhu YH and Wang HJ: Differential expression of microRNAs in GH-secreting pituitary adenomas. Diagn Pathol. 5(79)2010. View Article : Google Scholar : PubMed/NCBI
6	Nelson KM and Weiss GJ: MicroRNAs and cancer: Past, present, and potential future. Mol Cancer Ther. 7:3655–3660. 2008. View Article : Google Scholar : PubMed/NCBI
7	Esquela-Kerscher A and Slack FJ: Oncomirs - microRNAs with a role in cancer. Nat Rev Cancer. 6:259–269. 2006. View Article : Google Scholar : PubMed/NCBI
8	Bartel DP and Chen CZ: Micromanagers of gene expression: The potentially widespread influence of metazoan microRNAs. Nat Rev Genet. 5:396–400. 2004. View Article : Google Scholar : PubMed/NCBI
9	Nana-Sinkam SP and Croce CM: MicroRNAs as therapeutic targets in cancer. Transl Res. 157:216–225. 2011. View Article : Google Scholar : PubMed/NCBI
10	Gattolliat CH, Thomas L, Ciafrè SA, Meurice G, Le Teuff G, Job B, Richon C, Combaret V, Dessen P, Valteau-Couanet D, et al: Expression of miR-487b and miR-410 encoded by 14q32.31 locus is a prognostic marker in neuroblastoma. Br J Cancer. 105:1352–1361. 2011. View Article : Google Scholar : PubMed/NCBI
11	Yu G, Tang JQ, Tian ML, Li H, Wang X, Wu T, Zhu J, Huang SJ and Wan YL: Prognostic values of the miR-17-92 cluster and its paralogs in colon cancer. J Surg Oncol. 106:232–237. 2012. View Article : Google Scholar
12	Yan LX, Huang XF, Shao Q, Huang MY, Deng L, Wu QL, Zeng YX and Shao JY: MicroRNA miR-21 overexpression in human breast cancer is associated with advanced clinical stage, lymph node metastasis and patient poor prognosis. RNA. 14:2348–2360. 2008. View Article : Google Scholar : PubMed/NCBI
13	Wang Z, Liao H, Deng Z, Yang P, Du N, Zhanng Y and Ren H: miRNA-205 affects infiltration and metastasis of breast cancer. Biochem Biophys Res Commun. 441:139–143. 2013. View Article : Google Scholar : PubMed/NCBI
14	Wang S, Li H, Wang J and Wang D: Expression of microRNA-497 and its prognostic significance in human breast cancer. Diagn Pathol. 8(172)2013. View Article : Google Scholar
15	Ouyang M, Li Y, Ye S, Ma J, Lu L, Lv W, Chang G, Li X, Li Q, Wang S, et al: MicroRNA profiling implies new markers of chemoresistance of triple-negative breast cancer. PLoS One. 9:e962282014. View Article : Google Scholar : PubMed/NCBI
16	Peltier HJ and Latham GJ: Normalization of microRNA expression levels in quantitative RT-PCR assays: Identification of suitable reference RNA targets in normal and cancerous human solid tissues. RNA. 14:844–852. 2008. View Article : Google Scholar : PubMed/NCBI
17	Davoren PA, McNeill RE, Lowery AJ, Kerin MJ and Miller N: Identification of suitable endogenous control genes for microRNA gene expression analysis in human breast cancer. BMC Mol Biol. 9:76–87. 2008. View Article : Google Scholar : PubMed/NCBI
18	Lamba V, Ghodke-Puranik Y, Guan W and Lamba JK: Identification of suitable reference genes for hepatic microRNA quantitation. BMC Res Notes. 7:1292014. View Article : Google Scholar : PubMed/NCBI
19	Ratert N, Meyer HA, Jung M, Mollenkopf HJ, Wagner I, Miller K, Kilic E, Erbersdobler A, Weikert S and Jung K: Reference miRNAs for miRNAome analysis of urothelial carcinomas. PLoS One. 7:e393092012. View Article : Google Scholar : PubMed/NCBI
20	Mortarino M, Gioia G, Gelain ME, Albonico F, Roccabianca P, Ferri E and Comazzi S: Identification of suitable endogenous controls and differentially expressed microRNAs in canine fresh-frozen and FFPE lymphoma samples. Leuk Res. 34:1070–1077. 2010. View Article : Google Scholar
21	Li D, Liu H, Li Y, Yang M, Qu C, Zhang Y, Liu Y and Zhang X: Identification of suitable endogenous control genes for quantitative RT-PCR analysis of miRNA in bovine solid tissues. Mol Biol Rep. 41:6475–6480. 2014. View Article : Google Scholar : PubMed/NCBI
22	Chang KH, Mestdagh P, Vandesompele J, Kerin MJ and Miller N: MicroRNA expression profiling to identify and validate reference genes for relative quantification in colorectal cancer. BMC Cancer. 10(173)2010. View Article : Google Scholar
23	Genovesi LA, Anderson D, Carter KW, Giles KM and Dallas PB: Identification of suitable endogenous control genes for microRNA expression profiling of childhood medulloblastoma and human neural stem cells. BMC Res Notes. 5(507)2012. View Article : Google Scholar : PubMed/NCBI
24	McDermott AM, Kerin MJ and Miller N: Identification and validation of miRNAs as endogenous controls for RQ-PCR in blood specimens for breast cancer studies. PLoS One. 8:e837182013. View Article : Google Scholar
25	Mattie MD, Benz CC, Bowers J, Sensinger K, Wong L, Scott GK, Fedele V, Ginzinger D, Getts R and Haqq C: Optimized high-throughput microRNA expression profiling provides novel biomarker assessment of clinical prostate and breast cancer biopsies. Mol Cancer. 5(24)2006. View Article : Google Scholar : PubMed/NCBI
26	Kent OA, McCall MN, Cornish TC and Halushka MK: Lessons from miR-143/145: The importance of cell-type localization of miRNAs. Nucleic Acids Res. 42:7528–7538. 2014. View Article : Google Scholar : PubMed/NCBI
27	Selvakumar T, Gjidoda A, Hovde SL and Henry RW: Regulation of human RNA polymerase III transcription by DNMT1 and DNMT3a DNA methyltransferases. J Biol Chem. 287:7039–7050. 2012. View Article : Google Scholar : PubMed/NCBI
28	Lin BR and Natarajan V: Negative regulation of human U6 snRNA promoter by p38 kinase through Oct-1. Gene. 497:200–207. 2012. View Article : Google Scholar : PubMed/NCBI
29	Veras I, Rosen EM and Schramm L: Inhibition of RNA polymerase III transcription by BRCA1. J Mol Biol. 387:523–531. 2009. View Article : Google Scholar : PubMed/NCBI
30	Hu P, Samudre K, Wu S, Sun Y and Hernandez N: CK2 phosphorylation of Bdp1 executes cell cycle-specific RNA polymerase III transcription repression. Mol Cell. 16:81–92. 2004. View Article : Google Scholar : PubMed/NCBI
31	Rollins J, Veras I, Cabarcas S, Willis I and Schramm L: Human Maf1 negatively regulates RNA polymerase III transcription via the TFIIB family members Brf1 and Brf2. Int J Biol Sci. 3:292–302. 2007. View Article : Google Scholar : PubMed/NCBI
32	Marshall L and White RJ: Non-coding RNA production by RNA polymerase III is implicated in cancer. Nat Rev Cancer. 8:911–914. 2008. View Article : Google Scholar : PubMed/NCBI
33	Cabarcas S, Watabe K and Schramm L: Inhibition of U6 snRNA transcription by PTEN. Online J Biol Sci. 10:114–125. 2010. View Article : Google Scholar
34	Hilcenko C, Simpson PJ, Finch AJ, Bowler FR, Churcher MJ, Jin L, Packman LC, Shlien A, Campbell P, Kirwan M, et al: Aberrant 3′ oligoadenylation of spliceosomal U6 small nuclear RNA in poikiloderma with neutropenia. Blood. 121:1028–1038. 2013. View Article : Google Scholar
35	Mroczek S and Dziembowski A: U6 RNA biogenesis and disease association. Wiley Interdiscip Rev RNA. 4:581–592. 2013. View Article : Google Scholar : PubMed/NCBI